Investigation of generic 'cartel' expands to 300 drugs Print
Written by FHInews   
Tuesday, 11 December 2018 19:01
 
Chistopher Rowland reports, for the Washington Post on 12.9.18, about a case involving the generic pharmaceutical industry that is rapidly gaining steam. Investigators are looking into executives at more than a dozen generic-drug  companies over a massive price-fixing scheme, in what is being called potentially the largest U.S. drug cartel. The investigation reportedly began in 2016, in response to a complaint filed by states against two drugs. The ring of pharmaceutical companies has allegedly overcharged consumers and taxpayers for common drugs ranging from antibiotics to anxiety pills to asthma medication, authorities said. The effects have rippled throughout the health care sector, also affecting hospitals and insurance companies.

Read the Washington Post story HERE.
(Warning: Paywall may apply.)

Fox News does a nice summary of the WaPo article HERE.
(No paywall.)

Last Updated on Tuesday, 11 December 2018 19:05